MiRNA-mRNA crosstalk in esophageal cancer: From diagnosis to therapy

Critical Reviews in Oncology/Hematology

Volumn 96, Issue 3, 2015, Pages 449-462

  Sharma, Priyanka ^a   Sharma, Rinu ^a  

^a GURU GOBIND SINGH INDRAPRASTHA UNIVERSITY   (India)

Author keywords

Biomarkers; Diagnosis; Esophageal cancer; Invasion and metastasis; MiRNA; Oncogene prognosis; Therapy

Indexed keywords

CISPLATIN; DOXORUBICIN; FLUOROURACIL; IRINOTECAN; MESSENGER RNA; MICRORNA; MICRORNA 100; MICRORNA 106B; MICRORNA 10A; MICRORNA 127 3P; MICRORNA 133A; MICRORNA 143; MICRORNA 145; MICRORNA 148B; MICRORNA 18A; MICRORNA 196; MICRORNA 200C; MICRORNA 203; MICRORNA 205; MICRORNA 21; MICRORNA 22; MICRORNA 223; MICRORNA 25; MICRORNA 34A; MICRORNA 34B; MICRORNA 375; MICRORNA 93; MICRORNA LET 7C; PACLITAXEL; UNCLASSIFIED DRUG; UNINDEXED DRUG; TUMOR MARKER;

3' UNTRANSLATED REGION; APOPTOSIS; BARRETT ESOPHAGUS; CANCER DIAGNOSIS; CANCER GROWTH; CANCER PROGNOSIS; CANCER RECURRENCE; CANCER RISK; CANCER STAGING; CARCINOGENESIS; CELL CYCLE G0 PHASE; CELL PROLIFERATION; CELL SURVIVAL; CHEMORADIOTHERAPY; DNA REPLICATION; DOWN REGULATION; ENZYME INHIBITION; EPIGENETICS; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGEAL SQUAMOUS CELL CARCINOMA; G1 PHASE CELL CYCLE CHECKPOINT; G2 PHASE CELL CYCLE CHECKPOINT; HUMAN; IN VITRO STUDY; METASTASIS; MISMATCH REPAIR; PROTEIN EXPRESSION; RADIOSENSITIVITY; REVIEW; SIGNAL TRANSDUCTION; SINGLE NUCLEOTIDE POLYMORPHISM; TREATMENT RESPONSE; TUMOR INVASION; UPREGULATION; ESOPHAGEAL NEOPLASMS; GENE THERAPY; GENETICS; METABOLISM; PROGNOSIS;

BIOMARKERS, TUMOR; ESOPHAGEAL NEOPLASMS; GENETIC THERAPY; HUMANS; MICRORNAS; PROGNOSIS;

EID: 84983135130     PISSN: 10408428     EISSN: 18790461     Source Type: Journal    
DOI: 10.1016/j.critrevonc.2015.07.002     Document Type: Review

References (167)

1. Akagi I., Miyashita M., Ishibashi O., Mishima T., Kikuchi K., Makino H., Nomura T., Hagiwara N., Uchida E., Takizawa T. Relationship between altered expression levels of MIR21, MIR143, MIR145, and MIR205 and clinicopathologic features of esophageal squamous cell carcinoma. Dis. Esophagus 2011, 24(7):523-530. PubMed PMID 21453382.
2. Ambros V. A hierarchy of regulatory genes controls a larva regulatory specificity, the notion that target-site recogni- to-adult developmental switch in C. elegans. Cell 1989, 57(1):49-57. PubMed PMID. 2702689.
3. American Cancer Society Global Cancer Facts & Figures 2011, American Cancer Society, Atlanta. http://www.cancer.org/research/cancerfactsstatistics/index, 2nd Edition.
4. An Q., Robins P., Lindahl T., Barnes D.E. C→T mutagenesis and gamma-radiation sensitivity due to deficiency in the Smug1 and Ung DNA glycosylases. EMBO J. 2005, 24(12):2205-2213. PubMed PMID. 15902269.
5. Arroyo J.D., Chevillet J.R., Kroh E.M., Ruf I.K., Pritchard C.C., Gibson D.F., Mitchellm P.S., Bennett C.F., Pogosova-Agadjanyan E.L., Stirewalt D.L., Tait J.F., Tewari M. Argonaute2 complexes carry a population of circulating microRNAs independent of vesicles in human plasma. Proc. Natl. Acad. Sci. U. S. A. 2011, 22:5003-5008. Mar 22;108.
6. Asangani I.A., Rasheed S.A., Nikolova D.A., Leupold J.H., Colburn N.H., Post S., Allgayer H. MicroRNA-21 (miR-21) post-transcriptionally downregulates tumor suppressor Pdcd4 and stimulates invasion, intravasation and metastasis in colorectal cancer. Oncogene 2008, 27(15):2128-2136. PubMed PMID. 17968323.
7. Bansal A., Lee I.H., Hong X., Anand V., Mathur S.C., Gaddam S., Rastogi A., Wani S.B., Gupta N., Visvanathan M., Sharma P., Christenson L.K. Feasibility of mcroRNAs as biomarkers for Barrett's Esophagus progression: a pilot cross-sectional, phase 2 biomarker study. Am. J. Gastroenterol. 2011, 106(6):1055-1063. PubMed PMID.;1; 21407181.
8. Bitzer M., Stahl M., Arjumand J., Rees M., Klump B., Heep H., Gabbert H.E., Sarbia M. C-myc gene amplification in different stages of oesophageal squamous cell carcinoma: prognostic value in relation to treatment modality. Anticancer Res. 2003, 23(2B):1489-1493. PubMed PMID. 12820414.
9. Bommer G.T., Gerin I., Feng Y., Kaczorowski A.J., Kuick R., Love R.E., Zhai Y., Giordano T.J., Qin Z.S., Moore B.B., MacDougald O.A., Cho K.R., Fearon E.R. p53-mediated activation of miRNA34 candidate tumor-suppressor genes. Curr. Biol. 2007, 17(15):1298-1307. PubMed PMID.17656095.
10. Bucci B., D'Agnano I., Amendola D., Citti A., Raza G.H., Miceli R., De Paula U., Marchese R., Albini S., Felsani A., Brunetti E., Vecchione A. Myc down-regulation sensitizes melanoma cells to radiotherapy by inhibiting MLH1 and MSH2 mismatch repair proteins. Clin. Cancer Res. 2005, 11(7):2756-2767. PubMed PMID. 15814658.
11. Cai E.H., Gao Y.X., Wei Z.Z., Chen W.Y., Yu P., Li K. Serum miR-21 expression in human esophageal squamous cell carcinomas. Asian Pac. J. Cancer Prev. 2012, 13(4):1563-1567. PubMed PMID. 22799367.
12. Calin G.A., Croce C.M. MicroRNA signatures in human cancers. Nat. Rev. Cancer 2006, 6(November (1)):857-866. Review. PubMed PMID. 17060945.
13. Castillo S.D., Sanchez-Cespedes M. The SOX family of genes in cancer development: biological relevance and opportunities for therapy. Expert Opin. Ther. Targets 2012, 16(9):903-919. PubMed PMID. 22834733.
14. Chan J.A., Krichevsky A.M., Kosik K.S. MicroRNA-21 is an antiapoptotic factor in human glioblastoma cells. Cancer Res. 2005, 65(14):6029-6033. PubMed PMID. 16024602.
15. Chen X., Ba Y., Ma L., Cai X., Yin Y., Wang K., Guo J., Zhang Y., Chen J., Guo X., Li Q., Li X., Wang W., Zhang Y., Wang J., Jiang X., Xiang Y., Xu C., Zheng P., Zhang J., Li R., Zhang H., Shang X., Gong T., Ning G., Wang J., Zen K., Zhang J., Zhang C.Y. Characterization of microRNAs in serum: a novel class of biomarkers for diagnosis of cancer and other diseases. Cell Res. 2008, 18:997-1006. PubMed PMID.
16. Chen Z.L., Zhao X.H., Wang J.W., Li B.Z., Wang Z., Sun J., Tan F.W., Ding D.P., Xu X.H., Zhou F., Tan X.G., Hang J., Shi S.S., Feng X.L., He J. microRNA-92a promotes lymph node metastasis of human esophageal squamous cell carcinoma via E-cadherin. J. Biol. Chem. 2011, 286(12):10725-10734. Epub 2010 Dec 9. PubMed PMID. 21148309.
17. Choi H.J., Chung T.W., Kim S.J., Cho S.Y., Lee Y.S., et al. The AP-2alpha transcription factor is required for the ganglioside GM3-stimulated transcriptional regulation of a PTEN gene. Glycobiology 2008, 18:395-407. PubMed PMID. 18316341.
18. Chrzanowska-Wodnicka M., Kraus A.E., Gale D., White 2nd G.C., Vansluys J. Defective angiogenesis, endothelial migration, proliferation, and MAPK signaling in Rap1b-deficient mice. Blood 2008, 111(5):2647-2656. PubMed PMID. 17993608.
19. D'Souza-Schorey C. Disassembling adherens junctions: breaking up is hard to do. Trends Cell Biol. 2005, 15(1):19-26. Review. PubMed PMID. 15653074.
20. Dajee M., Lazarov M., Zhang J.Y., Cai T., Green C.L., Russell A.J., Marinkovich M.P., Tao S., Lin Q., Kubo Y., Khavari P.A. NF-kappaB blockade and oncogenic Ras trigger invasive human epidermal neoplasia. Nature 2003, 421(6923):639-643. PubMed PMID. 12571598.
21. Fang W.K., Liao L.D., Li L.Y., Xie Y.M., Xu X.E., Zhao W.J., Wu J.Y., Zhu M.X., Wu Z.Y., Du Z.P., Wu B.L., Xie D., Guo M.Z., Xu L.Y., Li E.M. Down-regulated desmocollin-2 promotes cell aggressiveness through redistributing adherens junctions and activating beta-catenin signalling in oesophageal squamous cell carcinoma. J. Pathol. 2013, 231(2):257-270. PubMed PMID. 23836524.
22. Fareed K.R., Kaye P., Soomro I.N., Ilyas M., Martin S., Parsons S.L., Madhusudan S. Biomarkers of response to therapy in oesophago-gastric cancer. Gut 2009, 58(1):127-143. Review. PubMed PMID. 19091831.
23. Fassan M., Volinia S., Palatini J., Pizzi M., Fernandez-Cymering C., Balistreri M., Realdon S., Battaglia G., Souza R., Odze R.D., Zaninotto G., Croce C.M., Rugge Md Facg M. MicroRNA expression profiling in the histological subtypes of Barrett's metaplasia. Clin. Transl. Gastroenterol. 2013, 4:e34. PubMed PMID. 23677165.
24. Feber A., Xi L., Luketich J.D., Pennathur A., Landreneau R.J., Wu M., Swanson S.J., Godfrey T.E., Litle V.R. MicroRNA expression profiles of esophageal cancer. J. Thorac. Cardiovasc. Surg. 2008, 135(2):255-260. PubMed PMID. 18242245.
25. Feber A., Xi L., Pennathur A., Gooding W.E., Bandla S., Wu M., Luketich J.D., Godfrey T.E., Litle V.R. MicroRNA prognostic signature for nodal metastases and survival in esophageal adenocarcinoma. Ann. Thorac. Surg. 2011, 91(5):1523-1530. PubMed PMID: 21420070.
26. Ferlay J, Soerjomataram I, Ervik M, Dikshit R, Eser S, Mathers C, Rebelo M, Parkin DM, Forman D, Bray, F.GLOBOCAN 2012 v1.0, Cancer Incidence and Mortality Worldwide: IARC CancerBase No. 11 [Internet].Lyon, France: International Agency for Research on Cancer; 2013. Available from: .
27. Frankel L.B., Christoffersen N.R., Jacobsen A., Lindow M., Krogh A., Lund A.H. Programmed cell death 4 (PDCD4) is an important functional target of the microRNA miR-21 in breast cancer cells. J. Biol. Chem. 2008, 283(January (2)):1026-1033. PubMed PMID. 17991735.
28. Frische E.W., Zwartkruis F.J. Rap1, a mercenary among the Ras-like GTPases. Dev. Biol. 2010, 340(1):1-9. Review. PubMed PMID. 20060392.
29. Fujita Y., Kojima K., Ohhashi R., Hamada N., Nozawa Y., Kitamoto A., Sato A., Kondo S., Kojima T., Deguchi T., Ito M. MiR-148a attenuates paclitaxel resistance of hormone-refractory, drug-resistant prostate cancer PC3 cells by regulating MSK1 expression. J. Biol. Chem. 2010, 285(25):19076-19084. PubMed PMID. 20406806.
30. Furuta M., Kozaki K.I., Tanaka S., Arii S., Imoto I., Inazawa J. miR-124 and miR-203 are epigenetically silenced tumor-suppressive microRNAs in hepatocellular carcinoma. Carcinogenesis 2010, 31(5):766-776. PubMed PMID. 19843643.
31. Göke R., Barth P., Schmidt A., Samans B., Lankat-Buttgereit B. Programmed cell death protein 4 suppresses CDK1/cdc2 via induction of p21(Waf1/Cip1). Am. J. Physiol. Cell Physiol. 2004, 287(6):C1541-C1546. PubMed PMID. 15317660.
32. Globocan, Global Cancer Facts & Figures 2nd Edition American Cancer Society. 2008;
33. Gong H., Song L., Lin C., Liu A., Lin X., Wu J., Li M., Li J. Downregulation of miR-138 sustains NF-(B activation and promotes lipid raft formation in esophageal squamous cell carcinoma. Clin. Cancer Res. 2013, 19(5):1083-1093. PubMed PMID. 23319823.
34. Guo Y., Chen Z., Zhang L., Zhou F., Shi S., Feng X., Li B., Meng X., Ma X., Luo M., Shao K., Li N., Qiu B., Mitchelson K., Cheng J., He J. Distinctive microRNA profiles relating to patient survival in esophageal squamous cell carcinoma. Cancer Res. 2008, 68(1):26-33. PubMed PMID. 18172293.
35. Gupta D., Boffetta P., Gaborieau V., Jindal S.K. Risk factors of lung cancer in Chandigarh India. Indian J. Med. Res. 2001, 113:142-150. PubMed PMID. 11558323.
36. Hamano R., Miyata H., Yamasaki M., Kurokawa Y., Hara J., Moon J.H., Nakajima K., Takiguchi S., Fujiwara Y., Mori M., Doki Y. Overexpression of miR-200c induces chemoresistance in esophageal cancers mediated through activation of the Akt signaling pathway. Clin. Cancer Res. 2011, 17(9):3029-3038. PubMed PMID. 21248297.
37. Harata K., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Ogawa R., Katada T., Tanaka T., Shiozaki M., Fujii Y. MicroRNA-34b has an oncogenic role in esophageal squamous cell carcinoma. Oncol. Lett. 2010, 1(4):685-689. PubMed PMID. 22966364.
38. Harazono Y., Muramatsu T., Endo H., Uzawa N., Kawano T., Harada K., Inazawa J., Kozaki K. miR-655 Is an EMT-suppressive microRNA targeting ZEB1 and TGFBR2. PLoS One 2013, 8(5):e62757. PubMed PMID. 23690952.
39. Hay N., Sonenberg N. Upstream and downstream of mTOR. Genes Dev. 2004, 18(16):1926-1945. Review. PubMed PMID. 15314020.
40. He X., He L., Hannon G.J. The guardian's little helper: microRNAs in the p53 tumor suppressor network. Cancer Res. 2007, 67(23):11099-11101. Review. PubMed PMID. 18056431.
41. Headrick J.R., Nichols F.C., Miller D.L., Allen M.S., Trastek V.F., Deschamps C., Schleck C.D., Thompson A.M., Pairolero P.C. High-grade esophageal dysplasia: long-term survival and quality of life after esophagectomy. Ann. Thorac. Surg. 2002, 73(6):1697-1702. discussion 1702-1703. PubMed PMID. 12078755.
42. Heneghan H.M., Miller N., Lowery A.J., Sweeney K.J., Newell J., Kerin M.J. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann. Surg. 2010, 251:499-505. PubMed PMID.
43. Hirajima S., Komatsu S., Ichikawa D., Takeshita H., Konishi H., Shiozaki A., Morimura R., Tsujiura M., Nagata H., Kawaguchi T., Arita T., Kubota T., Fujiwara H., Okamoto K., Otsuji E. Clinical impact of circulating miR-18a in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 2013, 108(9):1822-1829. PubMed PMID. 23579215.
44. Hiyoshi Y., Kamohara H., Karashima R., Sato N., Imamura Y., Nagai Y., Yoshida N., Toyama E., Hayashi N., Watanabe M., Baba H. MicroRNA-21 regulates the proliferation and invasion in esophageal squamous cell carcinoma. Clin. Cancer Res. 2009, 15(6):1915-1922. PubMed PMID. 19276261.
45. Hong L., Han Y., Zhang H., Li M., Gong T., Sun L., Wu K., Zhao Q., Fan D. The prognostic and chemotherapeutic value of miR-296 in esophageal squamous cell carcinoma. Ann. Surg. 2010, 251(6):1056-1063. PubMed PMID. 20485139.
46. Hu Y., Correa A.M., Hoque A., Guan B., Ye F., Huang J., Swisher S.G., Wu T.T., Ajani J.A., Xu X.C. Prognostic significance of differentially expressed miRNAs in esophageal cancer. Int. J. Cancer 2011, 128(1):132-143. PubMed PMID. 20309880.
47. Huang S.D., Yuan Y., Zhuang C.W., Li B.L., Gong D.J., Wang S.G., Zeng Z.Y., Cheng H.Z. MicroRNA-98 and microRNA-214 post-transcriptionally regulate enhancer of zeste homolog 2 and inhibit migration and invasion in human esophageal squamous cell carcinoma. Mol. Cancer 2012, 11:51. PubMed PMID. 22867052.
48. Hummel R., Watson D.I., Smith C., Kist J., Michael M.Z., Haier J., Hussey D.J. Mir-148a improves response to chemotherapy in sensitive and resistant oesophageal adenocarcinoma and squamous cell carcinoma cells. J. Gastrointest. Surg. 2011, 15(3):429-438. PubMed PMID. 21246413.
49. Hummel R., Wang T., Watson D.I., Michael M.Z., Van der Hoek M., Haier J., Hussey D.J. Chemotherapy-induced modification of microRNA expression in esophageal cancer. Oncol. Rep. 2011, 26(4):1011-1017. PubMed PMID. 21743970.
50. Imanaka Y., Tsuchiya S., Sato F., Shimada Y., Shimizu K., Tsujimoto G. MicroRNA-141 confers resistance to cisplatin-induced apoptosis by targeting YAP1 in human esophageal squamous cell carcinoma. J. Hum. Genet. 2011, 56(4):270-276. PubMed PMID. 21289630.
51. Jia Y., Yang Y., Zhan Q., Brock M.V., Zheng X., Yu Y., Herman J.G., Guo M. Inhibition of SOX17 by microRNA 141 and methylation activates the WNT signaling pathway in esophageal cancer. J. Mol. Diagn. 2012, 14(6):577-585. PubMed PMID. 22921431.
52. Kadera B.E., Li L., Toste P.A., Wu N., Adams C., Dawson D.W., Donahue T.R. MicroRNA-21 in pancreatic ductal adenocarcinoma tumor-associated fibroblasts promotes metastasis. PLoS One 1978, e71978. PubMed PMID. 23991015.
53. Kan T., Sato F., Ito T., Matsumura N., David S., Cheng Y., Agarwal R., Paun B.C., Jin Z., Olaru A.V., Selaru F.M., Hamilton J.P., Yang J., Abraham J.M., Mori Y., Meltzer S.J. The miR-106b-25 polycistron, activated by genomic amplification, functions as an oncogene by suppressing p21 and Bim. Gastroenterology 2009, 136(5):1689-1700. PubMed PMID. 19422085.
54. Kang M., Li Y., Liu W., Wang R., Tang A., Hao H., Liu Z., Ou H. miR-129-2 suppresses proliferation and migration of esophageal carcinoma cells through downregulation of SOX4 expression. Int. J. Mol. Med. 2013, 32(1):51-58. PubMed PMID. 23677061.
55. Kano M., Seki N., Kikkawa N., Fujimura L., Hoshino I., Akutsu Y., Chiyomaru T., Enokida H., Nakagawa M., Matsubara H. miR-145, miR-133a and miR-133b: tumor-suppressive miRNAs target FSCN1 in esophageal squamous cell carcinoma. Int. J. Cancer 2010, 127(12):2804-2814. PubMed PMID. 21351259.
56. Ke H., Pei J., Ni Z., Xia H., Qi H., Woods T., Kelekar A., Tao W. Putative tumor suppressor Lats2 induces apoptosis through downregulation of Bcl-2 and Bcl-x(L). Exp. Cell Res. 2004, 298(2):329-338. PubMed PMID. 15265683.
57. Kimura S., Naganuma S., Susuki D., Hirono Y., Yamaguchi A., Fujieda S., Sano K., Itoh H. Expression of microRNAs in squamous cell carcinoma of human head and neck and the esophagus: miR-205 and miR-21 are specific markers for HNSCC and ESCC. Oncol. Rep. 2010, 23(6):1625-1633. PubMed PMID. 20428818.
58. Ko M.A., Zehong G., Virtanen C., Guindi M., Waddell T.K., Keshavjee S., Darling G.E. MicroRNA expression profiling of esophageal cancer before and after induction chemoradiotherapy. Ann. Thorac. Surg. 2012, 94(4):1094-1102. discussion 1102-3. PubMed PMID. 22939244.
59. Komatsu S., Ichikawa D., Takeshita H., Tsujiura M., Morimura R., Nagata H., Kosuga T., Iitaka D., Konishi H., Shiozaki A., Fujiwara H., Okamoto K., Otsuji E. Circulating microRNAs in plasma of patients with oesophageal squamous cell carcinoma. Br. J. Cancer 2011, 105(1):104-111. PubMed PMID. 21673684.
60. Kosugi S., Nishimaki T., Kanda T., Nakagawa S., Ohashi M., Hatakeyama K. Clinical significance of serum carcinoembryonic antigen, carbohydrate antigen 19-9, and squamous cell carcinoma antigen levels in esophageal cancer patients. World J. Surg. 2004, 28:680-685. PubMed PMID.
61. Kurashige J., Watanabe M., Iwatsuki M., Kinoshita K., Saito S., Hiyoshi Y., Kamohara H., Baba Y., Mimori K., Baba H. Overexpression of microRNA-223 regulates the ubiquitin ligase FBXW7 in oesophageal squamous cell carcinoma. Br. J. Cancer 2012, 106(1):182-188. PubMed PMID. 22108521.
62. Kurashige J., Kamohara H., Watanabe M., Tanaka Y., Kinoshita K., Saito S., Hiyoshi Y., Iwatsuki M., Baba Y., Baba H. Serum microRNA-21 is a novel biomarker in patients with esophageal squamous cell carcinoma. J. Surg. Oncol. 2012, 106(2):188-192. PubMed PMID. 22354855.
63. Lawrie C.H., Gal S., Dunlop H.M., Pushkaran B., Liggins A.P., Pulford K., Banham A.H., Pezzella F., Boultwood J., Wainscoat J.S., Hatton C.S., Harris A.L. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br. J. Haematol. 2008, 141(5):672-675. PubMed PMID.
64. Lee R.C., Feinbaum R.L., Ambros V. The C. elegans heterochronic gene lin-4 encodes small RNAs with antisense complementarity to lin-14. Cell 1993, 75(5):843-854. PubMed PMID. 2702689.
65. Lee K.H., Goan Y.G., Hsiao M., Lee C.H., Jian S.H., Lin J.T., Chen Y.L., Lu P.J. MicroRNA-373 (miR-373) post-transcriptionally regulates large tumor suppressor, homolog 2 (LATS2) and stimulates proliferation in human esophageal cancer. Exp. Cell Res. 2009, 315(15):2529-2538. PubMed PMID. 19501585.
66. Leidner R.S., Ravi L., Leahy P., Chen Y., Bednarchik B., Streppel M., Canto M., Wang J.S., Maitra A., Willis J., Markowitz S.D., Barnholtz-Sloan J., Adams M.D., Chak A., Guda K. The microRNAs, MiR-31 and MiR-375, as candidate markers in Barrett's esophageal carcinogenesis. Genes Chromosomes Cancer 2012, 51(5):473-479. PubMed PMID. 22302717.
67. Li L., Ross A.H. Why is PTEN an important tumor suppressor?. Cell Biochem. 2007, 102(6):1368-1374. PubMed PMID. 17972252.
68. Li Y., Pei J., Xia H., Ke H., Wang H., Tao W. Lats2, a putative tumor suppressor,inhibits G1/S transition. Oncogene 2003, 22(28):4398-4405. PubMed PMID. 12853976.
69. Li N., Fu H., Tie Y., Hu Z., Kong W., Wu Y., Zheng X. miR-34a inhibits migration and invasion by down-regulation of c-Met expression in human hepatocellular carcinoma cells. Cancer Lett. 2009, 275(1):44-53. PubMed PMID. 19006648.
70. Li X., Lin R., Li J. Epigenetic silencing of microRNA-375 regulates PDK1 expression in esophageal cancer. Dig. Dis. Sci. 2011, 56(10):2849-2856. PubMed PMID. 21533613.
71. Li J., Wang K., Chen X., Meng H., Song M., Wang Y., Xu X., Bai Y. Transcriptional activation of microRNA-34a by NF-kappa B in human esophageal cancer cells. BMC Mol. Biol. 2012, 13:4. PubMed PMID. 22292433.
72. Li X.Q., Guo Y.Y., De W. DNA methylation and microRNAs in cancer. World J. Gastroenterol. 2012, 18(9):882-888. Review. PubMed PMID. 22408346.
73. Li P., Mao W.M., Zheng Z.G., Dong Z.M., Ling Z.Q. Down-regulation of PTEN expression modulated by dysregulated miR-21contributes to the progression of esophageal cancer. Dig. Dis. Sci. 2013, 58(12):3483-3493. PubMed PMID. 24221338.
74. Lin R.J., Xiao D.W., Liao L.D., Chen T., Xie Z.F., Huang W.Z., Wang W.S., Jiang T.F., Wu B.L., Li E.M., Xu L.Y. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. J. Surg. Oncol. 2012, 105(2):175-182. PubMed PMID. 21882196.
75. Liu Y., Wang J., Wu M., et al. Down-regulation of 3-phosphoinositide-dependent protein kinase-1 levels inhibits migration and experimental metastasis of human breast cancer cells. Mol. Cancer Res. 2009, 7:944-954. PubMed PMID.
76. Liu M., Wang Z., Yang S., Zhang W., He S., Hu C., Zhu H., Quan L., Bai J., Xu N. TNF-α is a novel target of miR-19a. Int. J. Oncol. 2011, 38(4):1013-1022. PubMed PMID. 21271217.
77. Liu Q., Lv G.D., Qin X., Gen Y.H., Zheng S.T., Liu T., Lu X.M. Role of microRNA let-7 and effect to HMGA2 in esophageal squamous cell carcinoma. Mol. Biol. Rep. 2012, 39(2):1239-1246. PubMed PMID. 21598109.
78. Liu R., Liao J., Yang M., Sheng J., Yang H., Wang Y., Pan E., Guo W., Pu Y., Kim S.J., Yin L. The cluster of miR-143 and miR-145 affects the risk for esophageal squamous cell carcinoma through co-regulating fascin homolog 1. PLoS One 2012, 7(3):e3987. PubMed PMID. 22457808.
79. Liu R., Liao J., Yang M., Shi Y., Peng Y., Wang Y., Pan E., Guo W., Pu Y., Yin L. Circulating miR-155 expression in plasma: a potential biomarker for early diagnosis of esophageal cancer in humans. J. Toxicol. Environ. Health A 2012, 75(18):1154-1162. PubMed PMID. 22891887.
80. Liu S.G., Qin X.G., Zhao B.S., Qi B., Yao W.J., Wang T.Y., Li H.C., Wu X.N. Differential expression of miRNAs in esophageal cancer tissue. Oncol. Lett. 2013, 5(5):1639-1642. PubMed PMID. 23761828.
81. Liu C., Cheng H., Shi S., Cui X., Yang J., Chen L., Cen P., Cai X., Lu Y., Wu C., Yao W., Qin Y., Liu L., Long J., Xu J., Li M., Yu X. MicroRNA-34b inhibits pancreatic cancer metastasis through repressing Smad3. Curr. Mol. Med. 2013, 13(4):467-478. PubMed PMID. 23305226.
82. Lu Z., Cox-Hipkin M.A., Windsor W.T., Boyapati A. 3-phosphoinositide-dependent protein kinase-1 regulates proliferation and survival of cancer cells with an activated mitogen-activated protein kinase pathway. Mol. Cancer Res. 2010, 8(3):421-432. PubMed PMID. 20197379.
83. Luthra R., Singh R.R., Luthra M.G., Li Y.X., Hannah C., Romans A.M., Barkoh B.A., Chen S.S., Ensor J., Maru D.M., Broaddus R.R., Rashid A., Albarracin C.T. MicroRNA-196a targets annexin A1: a microRNA-mediated mechanism of annexin A1 downregulation in cancers. Oncogene 2008, 27(52):6667-6678. PubMed PMID. 18663355.
84. Lynam-Lennon N., Reynolds J.V., Marignol L., Sheils O.M., Pidgeon G.P., Maher S.G. MicroRNA-31 modulates tumour sensitivity to radiation in oesophageal adenocarcinoma. J. Mol. Med. (Berl) 2012, 90(12):1449-1458. PubMed PMID. 22706599.
85. Ma W.J., Lv G.D., Tuersun A., Liu Q., Liu H., Zheng S.T., Huang C.G., Feng J.G., Wang X., Lin R.Y., Sheyhidin I., Lu X.M. Role of microRNA-21 and effect on PTEN in Kazakh's esophageal squamous cell carcinoma. Mol. Biol. Rep. 2011, 38(5):3253-3260. PubMed PMID. 21104017.
86. Maehama T., Dixon J.E. The tumor suppressor, PTEN/MMAC1, dephosphorylates the lipid second messenger, phosphatidylinositol 3,4,5-trisphosphate. J. Biol. Chem. 1998, 273:13375-13378. PubMed PMID. 9593664.
87. Maehama T.P.T.E.N. its deregulation and tumorigenesis. Biol. Pharm. Bull. 2007, 30(9):1624-1627. PubMed PMID. 17827710.
88. Majid S., Dar A.A., Saini S., Shahryari V., Arora S., Zaman M.S., Chang I., Yamamura S., Tanaka Y., Chiyomaru T., Deng G., Dahiya R. miRNA-34b inhibits prostate cancer through demethylation, active chromatin modifications, and AKT pathways. Clin. Cancer Res. 2013, 19(1):73-84. PubMed PMID. 23147995.
89. Maru D.M., Singh R.R., Hannah C., Albarracin C.T., Li Y.X., Abraham R., Romans A.M., Yao H., Luthra M.G., Anandasabapathy S., Swisher S.G., Hofstetter W.L., Rashid A., Luthra R. MicroRNA-196a is a potential marker of progression during Barrett's metaplasia-dysplasia-invasive adenocarcinoma sequence in esophagus. Am. J. Pathol. 2009, 174(5):1940-1948. PubMed PMID. 19342367.
90. Mathé E.A., Nguyen G.H., Bowman E.D., Zhao Y., Budhu A., Schetter A.J., Braun R., Reimers M., Kumamoto K., Hughes D., Altorki N.K., Casson A.G., Liu C.G., Wang X.W., Yanaihara N., Hagiwara N., Dannenberg A.J., Miyashita M., Croce C.M., Harris C.C. MicroRNA expression in squamous cell carcinoma and adenocarcinoma of the esophagus: associations with survival. Clin. Cancer Res. 2009, 15:6192-6200. PubMed PMID. 19789312.
91. Matsushima K., et al. MiRNA-205 modulates cellular invasion and migration via regulating zinc finger E-box binding homeobox 2 expression in esophageal squamous cell carcinoma cells. J. Transl. Med. 2011, 9:9. PubMed PMID. 21426561.
92. Mitchell P.S., Parkin R.K., Kroh E.M., Fritz B.R., Wyman S.K., Pogosova-Agadjanyan E.L., Peterson A., Noteboom J., O'Briant K.C., Allen A., Lin D.W., Urban N., Drescher C.W., Knudsen B.S., Stirewalt D.L., Gentleman R., Vessella R.L., Nelson P.S., Martin D.B., Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc. Natl. Acad. Sci. U. S. A. 2008, 105:10513-10518. PubMed PMID.
93. Mori Y., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Ogawa R., Katada T., Harata K., Tanaka T., Shiozaki M., Fujii Y. MicroRNA-21 induces cell proliferation and invasion in esophageal squamous cell carcinoma. Mol. Med. Rep. 2009, 2(2):235-239. PubMed PMID. 21475818.
94. Nakayama K.I., Nakayama K. Ubiquitin ligases: cell-cycle control and cancer. Nat. Rev. Cancer 2006, 6(5):369-381. Review. PubMed PMID. 16633365.
95. Ni Y., Meng L., Wang L., Dong W., Shen H., Wang G., Liu Q., Du J. MicroRNA-143 functions as a tumor suppressor in human esophageal squamous cell carcinoma. Gene 2013, 517(2):197-204. PubMed PMID. 23276710.
96. Odenthal M., Bollschweiler E., Grimminger P.P., Schröder W., Brabender J., Drebber U., Hölscher A.H., Metzger R., Vallböhmer D. MicroRNA profiling in locally advanced esophageal cancer indicates a high potential of miR-192 in prediction of multimodality therapy response. Int. J. Cancer 2013, 133(10):2454-2463. PubMed PMID. 23649428.
97. Ogawa R., Ishiguro H., Kuwabara Y., Kimura M., Mitsui A., Katada T., Harata K., Tanaka T., Fujii Y. Expression profiling of micro-RNAs in human esophageal squamous cell carcinoma using RT-PCR. Med. Mol. Morphol. 2009, 42(2):102-109. PubMed PMID. 19536617.
98. Ohbu M., Kobayashi N., Okayasu I. Expression of cell cycle regulatory proteins in the multistep process of oesophageal carcinogenesis: stepwise over-expression of cyclin E and p53, reduction of p21(WAF1/CIP1) and dysregulation of cyclin D1 and p27(KIP1). Histopathology 2001, 39(6):589-596. PubMed PMID. 11903577.
99. Ohtsu A. Chemoradiotherapy for esophageal cancer: current status and perspectives. J. Int. Clin. Oncol. 2004, 9(6):444-450. Review. PubMed PMID: 15616874.
100. Parkin D.M., Moss S.M. Lung cancer screening: improved survival but no reduction in deaths?the role of overdiagnosis. Cancer 2000, 89(Suppl. 11):2369-2376. PubMed PMID. 11147614.
101. Pennathur A., Gibson M.K., Jobe B.A., Luketich J.D. Oesophageal carcinoma. Lancet 2013, 381(9864):400-412. Review. PubMed PMID: 23374478. 10.1016/S0140-6736(12)60643-6.
102. Place R.F., Li L.C., Pookot D., Noonan E.J., Dahiya R. MicroRNA-373 induces expression of genes with complementary promoter sequences. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(5):1608-1613. PubMed PMID. 18227514.
103. Pulikkan J.A., Dengler V., Peramangalam P.S., Peer Zada A.A., Müller-Tidow C., Bohlander S.K., Tenen D.G., Behre G. Cell-cycle regulator E2F1 and microRNA-223 comprise an autoregulatory negative feedback loop in acute myeloid leukemia. Blood 2010, 115(9):1768-1778. PubMed PMID. 20029046.
104. Raver-Shapira N., Marciano E., Meiri E., Spector Y., Rosenfeld N., Moskovits N., Bentwich Z., Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol. Cell 2007, 26(5):731-743. PubMed PMID. 17540598.
105. Reed C.E. Surgical management of esophageal carcinoma. Oncologist 1999, 4(2):95-105. PMID. 10337379.
106. Resnick K.E., Alder H., Hagan J.P., Richardson D.L., Croce C.M., Cohn D.E. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol. Oncol. 2009, 112:55-59. PubMed PMID.
107. Revilla-Nuin B., Parrilla P., Lozano J.J., de Haro L.F., Ortiz A., Martínez C., Munitiz V., de Angulo D.R., Bermejo J., Molina J., Cayuela M.L., Yélamos J. Predictive value of MicroRNAs in the progression of Barrett esophagus to adenocarcinoma in a long-term follow-up study. Ann. Surg. 2013, 257(5):886-893. PubMed PMID. 23059500.
108. Ribeiro-Neto F., Urbani J., Lemee N., Lou L., Altschuler D.L. On the mitogenic properties of Rap1b: cAMP-induced G(1)/S entry requires activated and phosphorylated Rap1b. Proc. Natl. Acad. Sci. U. S. A. 2002, 99(8):5418-5423. PubMed PMID. 11959997.
109. Rodriguez A., Griffiths-Jones S., Ashurst J.L., Bradley A. Identification of mammalian microRNA host genes and transcription units. Genome Res. 2004, 14(10a):1902-1910. PubMed PMID. 1536490.
110. Rodriguez O.C., Lai E.W., Vissapragada S., et al. A reduction in PTEN tumor suppressor activity promotes ErbB-2-induced mouse prostate adenocarcinoma formation through the activation of signaling cascades downstream of PDK1. Am. J. Pathol. 2009, 174(6):2051-2060. PubMed PMID. 19443706.
111. Ruiz M., Pettaway C., Song R., Stoeltzing O., Ellis L., et al. Activator protein 2alpha inhibits tumorigenicity and represses vascular endothelial growth factor transcription in prostate cancer cells. Cancer Res. 2004, 64:631-638. PubMed PMID. 14744778.
112. Schwartz B., Melnikova V.O., Tellez C., Mourad-Zeidan A., Blehm K., et al. Loss of AP-2alpha results in deregulation of E-cadherin and MMP-9 and an increase in tumorigenicity of colon cancer cells in vivo. Oncogene 2007, 26:4049-4058. PubMed PMID. 17224907.
113. Seitz C.S., Deng H., Hinata K., Lin Q., Khavari P.A. Nuclear factor kappaB subunits induce epithelial cell growth arrest. Cancer Res. 2000, 60(15):4085-4092. PubMed PMID. 10945614.
114. Sharma P., Saraya A., Gupta P., Sharma R. Decreased levels of circulating and tissue miR-107 in human esophageal cancer. Biomarkers 2013, 18(4):322-330. PubMed PMID. 23627613.
115. Streppel M.M., Pai S., Campbell N.R., Hu C., Yabuuchi S., Canto M.I., Wang J.S., Montgomery E.A., Maitra A. MicroRNA 223 is upregulated in the multistep progression of Barrett's esophagus and modulates sensitivity to chemotherapy by targeting PARP1. Clin. Cancer Res. 2013, 19(15):4067-4078. PubMed PMID. 23757351.
116. Sugimura K., Miyata H., Tanaka K., Hamano R., Takahashi T., Kurokawa Y., Yamasaki M., Nakajima K., Takiguchi S., Mori M., Doki Y. Let-7 expression is a significant determinant of response to chemotherapy through the regulation of IL-6/STAT3 pathway in esophageal squamous cell carcinoma. Clin. Cancer Res. 2012, 18(18):5144-5153. PubMed PMID. 22847808.
117. Sun F., Fu H., Liu Q., Tie Y., Zhu J., Xing R., Sun Z., Zheng X. Downregulation of CCND1 and CDK6 by miR-34a induces cell cycle arrest. FEBS Lett. 2008, 582(10):1564-1568. PubMed PMID. 18406353.
118. Sun J., Chen Z., Tan X., Zhou F., Tan F., Gao Y., Sun N., Xu X., Shao K., He J. MicroRNA-99a/100 promotes apoptosis by targeting mTOR in human esophageal squamous cell carcinoma. Med. Oncol. 2013, 30(1):411. PubMed PMID. 23292834.
119. Takeshita N., Mori M., Kano M., Hoshino I., Akutsu Y., Hanari N., Yoneyama Y., Ikeda N., Isozaki Y., Maruyama T., Akanuma N., Miyazawa Y., Matsubara H. miR-203 inhibits the migration and invasion of esophageal squamous cell carcinoma by regulating LASP1. Int. J. Oncol. 2012, 41(5):1653-1661. PubMed PMID. 22940702.
120. Takeshita N., Hoshino I., Mori M., Akutsu Y., Hanari N., Yoneyama Y., Ikeda N., Isozaki Y., Maruyama T., Akanuma N., Komatsu A., Jitsukawa M., Matsubara H. Serum microRNA expression profile: miR-1246 as a novel diagnostic and prognostic biomarker for oesophageal squamous cell carcinoma. Br. J. Cancer 2013, 108(3):644-652. PubMed PMID. 23361059.
121. Tanaka Y., Kamohara H., Kinoshita K., Kurashige J., Ishimoto T., Iwatsuki M., Watanabe M., Baba H. Clinical impact of serum exosomal microRNA-21 as a clinical biomarker in human esophageal squamous cell carcinoma. Cancer 2013, 119(6):1159-1167. PubMed PMID. 23224754.
122. Tanaka K., Miyata H., Yamasaki M., Sugimura K., Takahashi T., Kurokawa Y., Nakajima K., Takiguchi S., Mori M., Doki Y. Circulating miR-200c levels significantly predict response to chemotherapy and prognosis of patients undergoing neoadjuvant chemotherapy for esophageal cancer. Ann. Surg. Oncol. 2013, 20(Suppl 3):S607-S615. PubMed PMID. 23838916.
123. Tarasov V., Jung P., Verdoodt B., Lodygin D., Epanchintsev A., Menssen A., Meister G., Hermeking H. Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest. Cell Cycle 2007, 6(13):1586-1593. PubMed PMID. 17554199.
124. Tazawa H., Tsuchiya N., Izumiya M., Nakagama H. Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells. Proc. Natl. Acad. Sci. U. S. A. 2007, 104(39):15472-15477. PubMed PMID. 17875987.
125. Tian Y., Luo A., Cai Y., Su Q., Ding F., Chen H., Liu Z. MicroRNA-10b promotes migration and invasion through KLF4 in human esophageal cancer cell lines. J. Biol. Chem. 2010, 285(11):7986-7994. PubMed PMID. 20075075.
126. Tsuchiya S., Fujiwara T., Sato F., Shimada Y., Tanaka E., Sakai Y., Shimizu K., Tsujimoto G. MicroRNA-210 regulates cancer cell proliferation through targeting fibroblast growth factor receptor-like 1 (FGFRL1). J. Biol. Chem. 2011, 286(1):420-428. PubMed PMID. 21044961.
127. Tsujiura M., Ichikawa D., Komatsu S., Shiozaki A., Takeshita H., Kosuga T., Konishi H., Morimura R., Deguchi K., Fujiwara H., Okamoto K., Otsuji E. Circulating microRNAs in plasma of patients with gastric cancers. Br. J. Cancer 2010, 102:1174-1179. PubMed PMID.
128. Wajapeyee N., Britto R., Ravishankar H.M., Somasundaram K. Apoptosis induction by activator protein 2alpha involves transcriptional repression of Bcl-2. J. Biol. Chem. 2006, 281:16207-16219. PubMed PMID. 16533807.
129. Wang J., Chen J., Chang P., LeBlanc A., Li D., Abbruzzesse J.L., Frazier M.L., Killary A.M., Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev. Res. (Phila Pa) 2009, 2:807-813. PubMed PMID.
130. Wang K., Li J., Guo H., Xu X., Xiong G., Guan X., Liu B., Li J., Chen X., Yang K., Bai Y. MiR-196a binding-site SNP regulates RAP1A expression contributing to esophageal squamous cell carcinoma risk and metastasis. Carcinogenesis 2012, 33(November (11)):2147-2154. Epub 2012 Aug 1. PubMed PMID. 22859270. 10.1093/carcin/bgs259.
131. Wang Y., Li M., Zang W., Ma Y., Wang N., Li P., Wang T., Zhao G. MiR-429 up-regulation induces apoptosis and suppresses invasion by targeting Bcl-2 and SP-1 in esophageal carcinoma. Cell Oncol. (Dordr) 2013, 36(5):385-394. PubMed PMID. 23999873. 10.1007/s13402-013-0144-6.
132. Wang X.C., Zhang Z.B., Wang Y.Y., Wu H.Y., Li D.G., Meng A.M., Fan F.Y. Increased miRNA-22 expression sensitizes esophageal squamous cell carcinoma to irradiation. J. Radiat. Res. 2013, 54(3):401-408. PubMed PMID. 23188185.
133. Wang Y., Zang W., Du Y., Ma Y., Li M., Li P., Chen X., Wang T., Dong Z., Zhao G. Mir-655 up-regulation suppresses cell invasion by targeting pituitary tumor-transforming gene-1 in esophageal squamous cell carcinoma. J. Transl. Med. 2013, 11:301. PubMed PMID. 24314023.
134. Wang L.G., Ni Y., Su B.H., Mu X.R., Shen H.C., Du J.J. MicroRNA-34b functions as a tumor suppressor and acts as a nodal point in the feedback loop with Met. Int. J. Oncol. 2013, 42(3):957-962. PubMed PMID. 23314612.
135. Wang F., Xia J., Wang N., Zong H. miR-145 inhibits proliferation and invasion of esophageal squamous cell carcinoma in part by targeting c-Myc. Onkologie 2013, 36(12):754-758. PubMed PMID. 24356567.
136. Wei L., Xu Z. Cross-signaling among phosphinositide-3 kinase, mitogen-activated protein kinase and sonic hedgehog pathways exists in esophageal cancer. Int. J. Cancer 2011, 129(2):275-284. PubMed PMID. 20839260.
137. Wei J.S., Song Y.K., Durinck S., Chen Q.R., Cheuk A.T., Tsang P., Zhang Q., Thiele C.J., Slack A., Shohet J., Khan J. The MYCN oncogene is a direct target of miR-34a. Oncogene 2008, 27(39):5204-5213. PubMed PMID. 18504438.
138. Welsh J., Amini A., Likhacheva A., Erasmus J.J., Gomez D., Davila M., Mehran R.J., Komaki R., Liao Z., Hofstetter W.L., Lee H.J., Bhutani M.S., Ajani J.A. Update modern approaches to the treatment of localized esophageal cancer. Curr. Oncol. Rep. 2011, 13(3):157-167. PubMed PMID. 21365188.
139. Wijnhoven B.P.L., Hussey D.J., Watson D.I., Tsykin A., Smith C.M., Michael M.Z. MicroRNA profiling of Barrett's oesophagus and oesophageal adenocarcinoma. Br. J. Surg. 2010, 97(6):853-861. PubMed PMID. 20301167.
140. Wu B.L., Xu L.Y., Du Z.P., Liao L.D., Zhang H.F., HuangQ, Fang G.Q., Li E.M. MiRNA profile in esophageal squamous cell carcinoma: downregulation of miR-143 and miR-145. World J. Gastroenterol. 2011, 17(1):79-88. PubMed PMID. 21,218,087.
141. Wu Y., Xiao Y., Ding X., Zhuo Y., Ren P., Zhou C., Zhou J. A miR-200b/200c/429-binding site polymorphism in the 3' untranslated region of the AP-2α gene is associated with cisplatin resistance. PLoS One 2011, 6(12):e2904. PubMed PMID. 22194984.
142. Wu C., Li M., Hu C., Duan H. Clinical significance of serum miR-223, miR-25 and miR-375 in patients with esophageal squamous cell carcinoma. Mol. Biol. Rep. 2014, 41(3):1257-1266. PubMed PMID. 24390317.
143. Xie Z., Chen G., Zhang X., Li D., Huang J., Yang C., Zhang P., Qin Y., Duan Y., Gong B., Li Z. Salivary microRNAs as promising biomarkers for detection of esophageal cancer. PLoS One 2013, 8(4):e7502. PubMed PMID. 23560033.
144. Xu X., Chen Z., Zhao X., Wang J., Ding D., Wang Z., Tan F., Tan X., Zhou F., Sun J., Sun N., Gao Y., Shao K., Li N., Qiu B., He J. MicroRNA-25 promotes cell migration and invasion in esophageal squamous cell carcinoma. Biochem. Biophys. Res. Commun. 2012, 421(4):640-645. PubMed PMID: 22450326.
145. Xu G., Zhang Y., Wei J., Jia W., Ge Z., Zhang Z., Liu X. MicroRNA-21 promotes hepatocellular carcinoma HepG2 cell proliferation through repression of mitogen-activated protein 3. BMC Cancer 2013, 13:469. PubMed PMID. 24112539.
146. Yamakuchi M., Ferlito M., Lowenstein C.J. miR-34a repression of SIRT1 regulates apoptosis. Proc. Natl. Acad. Sci. U. S. A. 2008, 105(36):13421-13426. PubMed PMID. 18755897.
147. Yang H.S., Jansen A.P., Nair R., Shibahara K., Verma A.K., Cmarik J.L., Colburn N.H. A novel transformation suppressor, Pdcd4, inhibits AP-1 transactivation but not NF-kappaB or ODC transactivation. Oncogene 2001, 20(6):669-676. PubMed PMID. 11314000.
148. Yang H.S., Jansen A.P., Komar A.A., Zheng X., Merrick W.C., Costes S., Lockett S.J., Sonenberg N., Colburn N.H. The transformation suppressor Pdcd4 is a novel eukaryotic translation initiation factor 4A binding protein that inhibits translation. Mol. Cell. Biol. 2003, 23(1):26-37. PubMed PMID. 12482958.
149. Yang H., Gu J., Wang K.K., Zhang W., Xing J., Chen Z., Ajani J.A., Wu X. MicroRNA expression signatures in Barrett's esophagus and esophageal adenocarcinoma. Clin. Cancer Res. 2009, 15(18):5744-5752. PubMed PMID. 19737949.
150. Yang M., Liu R., Sheng J., Liao J., Wang Y., Pan E., Guo W., Pu Y., Yin L. Differential expression profiles of microRNAs as potential biomarkers for the early diagnosis of esophageal squamous cell carcinoma. Oncol. Rep. 2013, 29(1):169-176. PubMed PMID. 23124769.
151. Yang S.M., Huang C., Li X.F., Yu M.Z., He Y., Li J. miR-21 confers cisplatin resistance in gastric cancer cells by regulating PTEN. Toxicology 2013, 306:162-168. PubMed PMID. 23466500.
152. Yeole B.B., Kumar A.V. Population-based survival from cancers having a poor prognosis in Mumbai (Bombay), India. Asian Pac. J. Cancer Prev. 2004, 5(2):175-182. PubMed PMID. 15244521.
153. Yokobori T., Suzuki S., Tanaka N., Inose T., Sohda M., Sano A., Sakai M., Nakajima M., Miyazaki T., Kato H., Kuwano H. MiR-150 is associated with poor prognosis in esophageal squamous cell carcinoma via targeting the EMT inducer ZEB1. Cancer Sci. 2013, 104(1):48-54. PubMed PMID. 23013135.
154. Yu X., Jiang X., Li H., Guo L., Jiang W., Lu S.H. miR-203 inhibits the proliferation and self-tenewal of esophageal cancer stem-like cells by suppressing stem renewal factor Bmi-1. Stem Cells Dev. 2014, 23(6):576-585. PubMed PMID. 24219349.
155. Yuan Y., Zeng Z.Y., Liu X.H., Gong D.J., Tao J., Cheng H.Z., Huang S.D. MicroRNA-203 inhibits cell proliferation by repressing (Np63 expression in human esophageal squamous cell carcinoma. BMC Cancer 2011, 11:57. PubMed PMID. 21299870.
156. Zeng Y.X., Somasundaram K., el-Deiry W.S. AP2 inhibits cancer cell growth and activates p21WAF1/CIP1 expression. Nat. Genet. 1997, 15:78-82. PubMed PMID. 8988173.
157. Zhang J.G., Wang J.J., Zhao F., Liu Q., Jiang K., Yang G.H. MicroRNA-21 (miR-21) represses tumor suppressor PTEN and promotes growth and invasion in non-small cell lung cancer (NSCLC). Clin. Chim. Acta 2010, 411(11-12):846-852. PubMed PMID. 20223231.
158. Zhang H., Li M., Han Y., Hong L., Gong T., Sun L., Zheng X. Down-regulation of miR-27a might reverse multidrug resistance of esophageal squamous cell carcinoma. Dig. Dis. Sci. 2010, 55(9):2545-2551. PubMed PMID. 19960259.
159. Zhang C., Wang C., Chen X., Yang C., Li K., Wang J., Dai J., Hu Z., Zhou X., Chen L., Zhang Y., Li Y., Qiu H., Xing J., Liang Z., Ren B., Yang C., Zen K., Zhang C.Y. Expression profile of microRNAs in serum: a fingerprint for esophageal squamous cell carcinoma. Clin. Chem. 2010, 56(12):1871-1879. PubMed PMID. 20943850.
160. Zhang T., Wang Q., Zhao D., Cui Y., Cao B., Guo L., Lu S.H. The oncogenetic role of microRNA-31 as a potential biomarker in oesophageal squamous cell carcinoma. Clin. Sci. (Lond) 2011, 121(10):437-447. PubMed PMID. 21658006.
161. Zhang M., Zhou S., Zhang L., Zhang J., Cai H., Zhu J., Huang C., Wang J. miR-518b is down-regulated, and involved in cell proliferation and invasion by targeting Rap1b in esophageal squamous cell carcinoma. FEBS Lett. 2012, 586(19):3508-3521. PubMed PMID. 22958893.
162. Zhao B.S., Liu S.G., Wang T.Y., Ji Y.H., Qi B., Tao Y.P., Li H.C., Wu X.N. Screening of microRNA in patients with esophageal cancer at same tumor node metastasis stage with different prognoses. Asian Pac. J. Cancer Prev. 2013, 14(1):139-143. PubMed PMID. 23534712.
163. Zhao Y., Schetter A.J., Yang G.B., Nguyen G., Mathé E.A., Li P., Cai H., Yu L., Liu F., Hang D., Yang H., Wang X.W., Ke Y., Harris C.C. microRNA and inflammatory gene expression as prognostic marker for overall survival in esophageal squamous cell carcinoma. Int. J. Cancer 2013, 132(12):2901-2909. PubMed PMID. 23175214.
164. Zhou L., Zhang X., Li Z., Zhou C., Li M., Tang X., Lu C., Li H., Yuan Q., Yang M. Association of a genetic variation in a miR-191 binding site in MDM4 with risk of esophageal squamous cell carcinoma. PLoS One 2013, 28(May (5)):e64331. PubMed PMID.
165. Zhu S., Si M.L., Wu H., Mo Y.Y. MicroRNA-21 targets the tumor suppressor gene tropomyosin 1 (TPM1). J. Biol. Chem. 2007, 282(19):14328-14336. PubMed PMID. 17363372.
166. Zhu L, Jin L, Jiang R, Wang Q, Jiang J, Mao C, Chen D. [Correlations between miRNAs and TGF-β1 in tumor microenvironment of esophageal squamous cell cancer]. Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi 2013; 29(5):524-8. Chinese. PubMed PMID. 23643275.
167. van Vuurden D.G., Hulleman E., Meijer O.L., Wedekind L.E., Kool M., Witt H., Vandertop P.W., Würdinger T., Noske D.P., Kaspers G.J., Cloos J. PARP inhibition sensitizes childhood high grade glioma, medulloblastoma and ependymoma to radiation. Oncotarget 2011, 2(12):984-996. PubMed PMID. 22184287.